Differential Shedding of Transmembrane Neuregulin Isoforms by the Tumor Necrosis Factor-α-Converting Enzyme

By Montero J.C.   Yuste L.   Díaz-Rodríguez E.   Esparís-Ogando A.   Pandiella A.  

Molecular and Cellular Neuroscience, Vol. 16, Iss. 5, 2000-11 ,pp. : 631-648

Academic Press

Access to resources Recommend Favorite

Differential expression of matrix metalloproteinases in bacterial meningitis

By Kieseier Bernd C.   Paul Robert   Koedel Uwe   Seifert Thomas   Clements John M.   Gearing Andrew J. H.   Pfister Hans-Walter  

Brain, Vol. 122, Iss. 8, 1999-08 ,pp. : 1579-1587

Oxford University Press

Access to resources Recommend Favorite

Neuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition

By Vinukonda Govindaiah  

Brain, Vol. 133, Iss. 8, 2010-08 ,pp. : 2264-2280

Oxford University Press

Access to resources Recommend Favorite

Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination

By Brambilla Roberta  

Brain, Vol. 134, Iss. 9, 2011-09 ,pp. : 2736-2754

Oxford University Press

Access to resources Recommend Favorite

Novel therapy approach in primary stroke prevention: simultaneous inhibition of endothelin converting enzyme and neutral endopeptidase in spontaneously hypertensive, stroke-prone rats improves survival

By Wengenmayer Christina   Krikov Maxim   Mueller Susanne   Lucht Kristin   Villringer Arno   Hocher Berthold   Unger Thomas   Thoene-Reineke Christa  

Neurological Research, Vol. 33, Iss. 2, 2011-03 ,pp. : 201-207

Maney Publishing

Access to resources Recommend Favorite